Patent ID: 7956041
Filing Date: 2011-06-07
Classification: A61K

Abstract:
1. A therapeutic agent of diabetes mellitus, comprising a combination of an inhibitor of renal glucose reabsorption and a hypoglycemic agent, wherein said hypoglycemic agent is at least one selected from the group consisting of glibenclamide, nateglinide, and metformin, and said inhibitor of renal glucose reabsorption is at least one selected from the group consisting of: a pyrazole derivative of formulae (1) and/or (2) or a pharmaceutically acceptable salt thereof: wherein a pyrazole derivative of formulae (1A) and/or (2A) or a pharmaceutically acceptable salt thereof: wherein at least one selected from a pyrazole-o-glycoside derivative of formula (5) or a pharmaceutically acceptable salt thereof: wherein at least one selected from a glucopyranosyloxypyrazole derivative of formula (8) or a pharmaceutically acceptable salt thereof: wherein